BCKDHB and diabetic kidney disease: In our study, we found that patients with DKD had lower plasma levels of 3-methyl-2-oxobutyrate and abnormal upregulation of circulating BCAT1 and BCKDHB, which can promote valine metabolism (Nie et al. 2018).